Latest News and Press Releases
Want to stay updated on the latest news?
-
ALISO VIEJO, Calif., April 29, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that a request for a preliminary injunction, filed by Hologic and its wholly-owned subsidiaries,...
-
ALISO VIEJO, Calif., April 15, 2008 (PRIME NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will release its first quarter 2008 financial results on Tuesday, May 13, 2008 prior to the market...
-
ALISO VIEJO, Calif., April 10, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has received approval to apply the CE Mark to its SenoSonix(tm) with EnCor, an integration of...
-
ALISO VIEJO, Calif., April 3, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has launched EnCor(r), its flagship vacuum-assisted breast biopsy product, and its line of...
-
ALISO VIEJO, Calif., March 6, 2008 (PRIME NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will be presenting at the following...
-
ALISO VIEJO, Calif., Feb. 19, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its fourth quarter and year ended December 31, 2007. Revenue for the quarter...
-
ALISO VIEJO, Calif., Feb. 1, 2008 (PRIME NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will release its fourth quarter and full-year 2007 financial results on Tuesday, February 19, 2008...
-
ALISO VIEJO, Calif., Jan. 17, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has launched Contura(tm), its Multi-Lumen Balloon (MLB) Catheter for delivering brachytherapy...
-
ALISO VIEJO, Calif., Jan. 11, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO), a company that manufactures and sells minimally invasive medical devices used by breast care specialists for the...
-
ALISO VIEJO, Calif., Dec. 20, 2007 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today provided its initial estimate for revenues in 2008, which it expects will be in a range of $46 million to $50...